Supersaturated Oxygen Delivery & Acute MI: Current Evidence, Practical Issues, and Future Research

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• Acute myocardial infarction (MI) is a leading cause of mortality worldwide.
• Early reperfusion via coronary angiography improves outcomes.
• Supersaturated Oxygen (SSO2) Therapy emerges as a novel intervention for post-ischemic recovery.

Purpose of the Study:

• To evaluate the efficacy of SSO2 therapy in improving post-myocardial infarction outcomes.
• To assess the impact of SSO2 on left ventricular function, myocardial scarring, and cardiac morphology.

Main Methods:

• Review of pre-clinical animal studies and early clinical trials on SSO2 therapy.
• SSO2 therapy involves delivering oxygen at 10x normal levels to the infarcted artery before reperfusion.

Main Results:

• Pre-clinical data show enhanced Left Ventricular Ejection Fraction (LVEF), reduced apoptosis, and smaller infarct sizes.
• Clinical trials (e.g., AMIHOT I/II) indicate improved regional wall motion and prevention of cardiac remodeling.

Conclusions:

• SSO2 therapy is a promising advancement for acute myocardial infarction treatment.
• Early results suggest significant improvements in cardiac function and tissue preservation.
• Long-term studies are essential to evaluate effects on mortality and healthcare utilization.